false
OasisLMS
Login
Catalog
The Lead Episode 178: A Discussion of Safety and P ...
The Lead Episode 178 Video
The Lead Episode 178 Video
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The ASCEND-CSP trial evaluated a modified ICD lead designed for left bundle branch area pacing, combining defibrillation and conduction-system pacing in one lead. In this global, single-arm study, 205 patients received an implant attempt; 202 had successful implantation. At three months, the lead met its predefined safety and effectiveness goals: 97.5% were free of major complications, and effectiveness was 94.6%. Defibrillation testing succeeded in all tested patients, with 92.5% terminated by a 20-joule shock. Pacing and sensing measures remained stable.<br /><br />The findings are encouraging, but follow-up was short, pacing-site classification was not independently adjudicated, and broader experience is needed to establish reproducibility. Experts also raised questions about long-term tricuspid-valve effects and lead extraction, given the coil’s position and lead thickness. For now, the lead may suit selected patients, but it is not yet a proven substitute for standard CRT-D or established pacing approaches.
Keywords
ASCEND-CSP trial
ICD lead
left bundle branch area pacing
defibrillation testing
cardiac resynchronization therapy
×
Please select your language
1
English